NBHIGH SIGNALFINANCIAL10-K

NioCorp completed a significant equity raise in July 2025 that substantially improved its balance sheet position while diluting existing shareholders by roughly doubling the share count.

The dramatic reduction in debt levels and current liabilities signals that NioCorp used proceeds from the July 2025 equity offering to clean up its balance sheet and improve liquidity. However, the share count increase from 38.7 million to 77.8 million shares represents substantial dilution for existing investors, effectively cutting their ownership stakes in half.

Comparing 2025-09-11 vs 2024-09-23View on EDGAR →
FINANCIAL ANALYSIS

NioCorp's financial position improved markedly with total debt declining 90% to just $344K and current liabilities falling 84% to $1.9M, indicating successful debt reduction from the equity raise. However, net losses expanded meaningfully to $18.0M while interest expense roughly doubled despite lower debt levels, suggesting higher borrowing costs on remaining obligations. The overall picture shows a company that has addressed near-term liquidity concerns through equity financing but at the cost of significant shareholder dilution and continued operating losses.

FINANCIAL STATEMENT CHANGES
Interest Expense
P&L
+92.2%
$2.3M→$4.5M

Interest expense surged 92.2% — significant debt increase or rising rates materially impacting earnings.

Total Debt
Balance Sheet
-90.2%
$3.5M→$344K

Debt reduced 90.2% — deleveraging strengthens balance sheet and reduces financial risk.

Capital Expenditure
Cash Flow
-85.2%
$27K→$4K

Capex reduced 85.2% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Current Liabilities
Balance Sheet
-84.2%
$12.0M→$1.9M

Current liabilities reduced — improved short-term financial position and working capital health.

Net Income
P&L
-51.1%
-$11.9M→-$18.0M

Net income declined 51.1% — review whether driven by operations, interest costs, or non-recurring items.

Total Liabilities
Balance Sheet
-16.4%
$17.5M→$14.7M

Liabilities reduced 16.4% — deleveraging improves balance sheet strength and financial flexibility.

LANGUAGE CHANGES
NEW — 2025-09-11
PRIOR — 2024-09-23
ADDED
false FY 2025 --06-30 0001512228 A1 62900000 Unlimited Unlimited 1 17982 11898 P2Y P2Y 2881 P1Y7M6D 139 Maxim acted as sole placement agent for the July 2025 Offering.
The Company intends to use the net proceeds from the July 2025 Offering for working capital and general corporate purposes, including to advance its efforts to launch construction of the Elk Creek Project and move it to commercial operation.
There were 77,757,089 common shares outstanding on September 11, 2025.
BUSINESS 1 Introduction 1 Business Operations 1 Corporate Structure 1 Historical Development of the Business 2 Recent Corporate Events 3 Competitive Business Conditions 4 Cycles 4 Economic Dependence 4 Government Regulation 5 Human Capital 7 Forward-Looking Statements 7 Available Information 9 ITEM 1A.
RISK FACTORS 9 Risks Related to Our Business 9 Risks Related to Mining and Development 15 Risks Related to Government Regulation 19 Risks Related to Our Debt 21 Risks Related to the Common Shares 21 ITEM 1B.
MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 45 Summary of Consolidated Financial and Operating Performance 45 Results of Operations 45 Liquidity and Capital Resources 47 Cash Flow Considerations 50 Environmental 51 Forward-Looking Statements 51 Accounting Developments 51 Critical Accounting Estimates and Recent Accounting Pronouncements 51 Other 52 ITEM 7A.
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.
Fiscal Year Ended June 30, 2025 2024 Canadian Dollars to U.S.
Dollars Rate at end of period 0.7330 0.7306 Average rate for period 0.7170 0.7380 High for period 0.7429 0.7617 Low for period 0.6848 0.7207 Risk Factors Summary Investing in common shares, no par value, of the Company ( Common Shares ) involves numerous risks and uncertainties, as more fully described below.
NioCorp is a United States Securities and Exchange Commission ( SEC ) reporting company, and we are also a Canadian reporting issuer in British Columbia, Alberta, Saskatchewan, Ontario, and New Brunswick.
REMOVED
There were 38,660,244 common shares outstanding on September 20, 2024.
BUSINESS 1 Introduction 1 Historical Development of the Business 1 Business Operations 5 Competitive Business Conditions 6 Cycles 6 Economic Dependence 7 Government Regulation 7 Human Capital 9 Forward-Looking Statements 9 Available Information 11 ITEM 1A.
RISK FACTORS 11 Risks Related to Our Business 12 Risks Related to Mining and Development 17 Risks Related to Government Regulation 21 Risks Related to Our Debt 23 Risks Related to the Common Shares 24 ITEM 1B.
MANAGEMENT S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 49 Summary of Consolidated Financial and Operating Performance 49 Results of Operations 49 Liquidity and Capital Resources 51 Cash Flow Considerations 56 Environmental 56 Forward-Looking Statements 56 Accounting Developments 57 Critical Accounting Estimates and Recent Accounting Pronouncements 57 Other 58 ITEM 7A.
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE 97 ITEM 9A.
DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE 100 Directors and Executive Officers 100 ITEM 11.
Fiscal Year Ended June 30, 2024 2023 Canadian Dollars to U.S.
Dollars Rate at end of period 0.7306 0.7553 Average rate for period 0.7380 0.7467 High for period 0.7617 0.7841 Low for period 0.7207 0.7217 Risk Factors Summary Investing in our Common Shares (as defined herein) involves numerous risks and uncertainties, as more fully described below.
The Company may not realize all or any of the anticipated benefits expected as a result of the 2023 Transactions (as defined herein).
We may not have the ability to service our debt, including, without limitation, to pay the installments on the April 2024 Notes (as defined herein).
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →